Paper40211010
Oroxylin A may promote cell apoptosis and inhibit epithelial-mesenchymal transition in endometrial cancer, associated with the ERβ/PI3K/AKT pathway.
Fan X and 8 others. Sci Rep, 2025. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Oroxylin A may promote cell apoptosis and inhibit epithelial-mesenchymal transition in endometrial cancer, associated with the ERβ/PI3K/AKT pathway. Papers, record 40211010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40211010
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Oroxylin A may promote cell apoptosis and inhibit epithelial-mesenchymal transition in endometrial cancer, associated with the ERβ/PI3K/AKT pathway.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Epithelial-Mesenchymal Transition | Major topic |
| Apoptosis | Major topic |
| Flavonoids | Major topic |
| Proto-Oncogene Proteins c-akt | Major topic |
| Phosphatidylinositol 3-Kinases | Major topic |
| Endometrial Neoplasms | Major topic |
| Signal Transduction | Major topic |
| Estrogen Receptor beta | Major topic |
| Female | |
| Humans | |
| Animals | |
| Mice | |
| Cell Line, Tumor | |
| Mice, Nude | |
| Mice, Inbred BALB C | |
| Cell Proliferation | |
| Xenograft Model Antitumor Assays | |
| Cell Movement |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 24JRRA910 | the Science and Technology Program of Gansu Province | PubMed |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36932403 | An integrated approach of network pharmacology, molecular docking, and experimental verification uncovers kaempferol as the effective modulator of HSD17B1 for treatment of endometrial cancer. | J Transl Med | 2023 | https://conductscience.org/library/papers/36932403 | PubMed |
| 2 | 32901849 | Targeting CDK9: A novel biomarker in the treatment of endometrial cancer. | Oncol Rep | 2020 | https://conductscience.org/library/papers/32901849 | PubMed |
| 3 | 32512269 | ROS-dependent inhibition of the PI3K/Akt/mTOR signaling is required for Oroxylin A to exert anti-inflammatory activity in liver fibrosis. | Int Immunopharmacol | 2020 | https://conductscience.org/library/papers/32512269 | PubMed |
| 4 | 37714256 | Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer. | Cancer Lett | 2023 | https://conductscience.org/library/papers/37714256 | PubMed |
| 5 | 36139025 | Oroxylin A: A Promising Flavonoid for Prevention and Treatment of Chronic Diseases. | Biomolecules | 2022 | https://conductscience.org/library/papers/36139025 | PubMed |
| 6 | 36214865 | Anticancer potential of oroxylin A: from mechanistic insight to synergistic perspectives. | Naunyn Schmiedebergs Arch Pharmacol | 2023 | https://conductscience.org/library/papers/36214865 | PubMed |
| 7 | 23922737 | An estrogen receptor dependent mechanism of Oroxylin A in the repression of inflammatory response. | PLoS One | 2013 | https://conductscience.org/library/papers/23922737 | PubMed |
| 8 | 34188177 | Novel CDK9 inhibitor oroxylin A promotes wild-type P53 stability and prevents hepatocellular carcinoma progression by disrupting both MDM2 and SIRT1 signaling. | Acta Pharmacol Sin | 2022 | https://conductscience.org/library/papers/34188177 | PubMed |
| 9 | 23399685 | Involvement of estrogen receptor β5 in the progression of glioma. | Brain Res | 2013 | https://conductscience.org/library/papers/23399685 | PubMed |
| 10 | 15941045 | Isolation and purification of baicalein, wogonin and oroxylin A from the medicinal plant Scutellaria baicalensis by high-speed counter-current chromatography. | J Chromatogr A | 2005 | https://conductscience.org/library/papers/15941045 | PubMed |
| 11 | 33535622 | The Role of Gonadotropin-Releasing Hormone (GnRH) in Endometrial Cancer. | Cells | 2021 | https://conductscience.org/library/papers/33535622 | PubMed |
| 12 | 31168597 | Picropodophyllin inhibits type I endometrial cancer cell proliferation via disruption of the PI3K/Akt pathway. | Acta Biochim Biophys Sin (Shanghai) | 2019 | https://conductscience.org/library/papers/31168597 | PubMed |
| 13 | 30423148 | Molecular-targeted therapies and precision medicine for endometrial cancer. | Jpn J Clin Oncol | 2019 | https://conductscience.org/library/papers/30423148 | PubMed |
| 14 | 23934681 | Oroxylin A has therapeutic potential in acute myelogenous leukemia by dual effects targeting PPARγ and RXRα. | Int J Cancer | 2014 | https://conductscience.org/library/papers/23934681 | PubMed |
| 15 | 28726775 | Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression. | Cell Death Dis | 2017 | https://conductscience.org/library/papers/28726775 | PubMed |
| 16 | 34117368 | Oroxylin A inhibits the migration of hepatocellular carcinoma cells by inducing NAG-1 expression. | Acta Pharmacol Sin | 2022 | https://conductscience.org/library/papers/34117368 | PubMed |
| 17 | 25100707 | Influence of AKT on progesterone action in endometrial diseases. | Biol Reprod | 2014 | https://conductscience.org/library/papers/25100707 | PubMed |
| 18 | 31299894 | YAP promotes the malignancy of endometrial cancer cells via regulation of IL-6 and IL-11. | Mol Med | 2019 | https://conductscience.org/library/papers/31299894 | PubMed |
| 19 | 37209937 | Saikosaponin D exerts cytotoxicity on human endometrial cancer ishikawa cells by inducing apoptosis and inhibiting metastasis through MAPK pathways. | Food Chem Toxicol | 2023 | https://conductscience.org/library/papers/37209937 | PubMed |
| 20 | 30948788 | The molecular machinery of regulated cell death. | Cell Res | 2019 | https://conductscience.org/library/papers/30948788 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42194035 | Oroxylin A Directly Targets SRC to Inhibit the PI3K/AKT Signaling Axis in Pancreatic Cancer: An Integrated Bioinformatics and Experimental Study. | Biomolecules | 2026 | https://conductscience.org/library/papers/42194035 | PubMed |
| 42004947 | Astragaloside IV suppresses neuroinflammation via PI3K/Akt/NF-κB to ameliorate cerebral ischemia-reperfusion injury based on network pharmacology analysis and experimental validation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42004947 | PubMed |
| 41743243 | Antitumor Effects of Apatinib on Tongue Cancer in Patient-Derived Xenograft Models. | Iran J Med Sci | 2026 | https://conductscience.org/library/papers/41743243 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| BAX | 581 | PubTator's text mining | https://conductscience.org/library/genes/581 | NCBI Gene |
| BCL2 | 596 | PubTator's text mining | https://conductscience.org/library/genes/596 | NCBI Gene |
| CASP3 | 836 | PubTator's text mining | https://conductscience.org/library/genes/836 | NCBI Gene |
| CDH1 | 999 | PubTator's text mining | https://conductscience.org/library/genes/999 | NCBI Gene |
| CDH2 | 1000 | PubTator's text mining | https://conductscience.org/library/genes/1000 | NCBI Gene |
| ESR2 | 2100 | PubTator's text mining | https://conductscience.org/library/genes/2100 | NCBI Gene |
| MMP2 | 4313 | PubTator's text mining | https://conductscience.org/library/genes/4313 | NCBI Gene |
| MMP9 | 4318 | PubTator's text mining | https://conductscience.org/library/genes/4318 | NCBI Gene |
| VIM | 7431 | PubTator's text mining | https://conductscience.org/library/genes/7431 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40211010
GET https://conductscience.org/api/papers/v1/40211010/references?page=2